News
What is new at Keyline.
Press releases, lab updates and where to meet us.
Talk at a protein design meeting in Boston (sample event)
Our team shows one full loop, from design to lab result.
Read the full story →Nothing matches. Try another filter.
How we design binders for flat protein surfaces
A new preprint shows our approach for targets without a deep pocket.
Press releaseFirst patient dosed in the Phase 1 study of KL-101
Keyline's first clinical study is open in recurrent or metastatic head and neck cancer.
NewsOur lab now screens 12,000 designs a week
A second robot line and a new binding assay double what we can test.
Press releaseKeyline raises $140M Series B
The funding supports the Phase 1 study of KL-101 and grows the design and lab platform.
Press releaseIND for KL-101 now in effect
Keyline can now start the first clinical study of a protein it designed.
Press releaseKeyline and Aldermoor start a partnership in autoimmune disease
Keyline will design binders for one target chosen by Aldermoor.
Media contact
For interviews, images and our press kit, write to press@keyline.xiobocreative.com. To follow our news, use the RSS feed.
Help design the next protein therapies.
We are a team of protein designers, lab scientists and engineers in Cambridge, MA.